$4.68 -$0.29 (-5.8%)

04:00 PM EST on 12/10/19

Aridis Pharmaceuticals (NASDAQ:ARDS)

CAPS Rating: No stars

Current Price $4.68 Mkt Cap $44.3M
Open $4.91 P/E Ratio 0.00
Prev. Close $4.97 Div. (Yield) $0.00 (0.0%)
Daily Range $4.65 - $4.93 Volume 6,088
52-Wk Range $4.39 - $12.40 Avg. Daily Vol. 5,488

Caps

How do you think NASDAQ:ARDS will perform against the market?

Add Stock to CAPS Watchlist

All Players

1 Outperform
4 Underperform
 

All-Star Players

1 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ARDS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:ARDS VS S&P 500 (SPY)

NASDAQ:ARDS Summary

Recent Community Commentary

Read the most recent pitches from players about ARDS.

Recs

0
Member Avatar SmartAce (99.97) Submitted: 10/10/2019 1:43:43 PM : Underperform Start Price: $5.90 NASDAQ:ARDS Score: +27.25

Before coffee: I want to die
After coffee: Alright! Let's buy the rope

Leaderboard

Find the members with the highest scoring picks in ARDS.

Score Leader

HDTVBG

HDTVBG (59.57) Score: +102.03

The Score Leader is the player with the highest score across all their picks in ARDS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
wolfhounds 97.43 10/11/2019 Underperform 5Y $7.11 -34.18% +5.66% +39.84 0 Comment
SmartAce 99.97 10/10/2019 Underperform 5Y $5.90 -20.68% +6.58% +27.25 1 Comment
Smiley81 < 20 10/28/2019 Underperform 5Y $5.85 -20.00% +3.46% +23.46 0 Comment
JCSmiley81 69.14 12/4/2019 Underperform 5Y $5.35 -12.52% +0.87% +13.40 0 Comment
PAGEBOY54 96.36 11/21/2019 Outperform 1Y $4.84 -3.31% +0.97% -4.28 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARDS.